Literature DB >> 6606418

Complement allotyping in SLE: association with C4A null.

F T Christiansen, R L Dawkins, G Uko, J McCluskey, P H Kay, P J Zilko.   

Abstract

Immunogenetic factors are important in systemic lupus erythematosus (SLE) and deficiency of a number of complement components is often associated with a lupus-like illness. The complement components Bf, C2 and C4 are encoded within the human major histocompatibility complex (MHC) and are polymorphic. A study of HLA and Bf and C4 polymorphism in 43 patients with SLE was undertaken firstly, to determine whether partial deficiency of C2 and C4 may predispose to disease and secondly, because it may allow the better definition of important supratypes associated with the disease and which may include the relevant disease gene(s). An increased frequency of C4A null alleles has been shown in SLE, with a minimal estimated C4A null gene frequency of 0.32 versus 0.20, but no case of partial C2 deficiency was identified. These results may indicate a direct role for partial C4 deficiency or that C4A null may be a marker for an important supratype which includes the relevant disease gene(s).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606418     DOI: 10.1111/j.1445-5994.1983.tb02699.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  33 in total

1.  Assessment of complement C4 gene copy number using the paralog ratio test.

Authors:  Michelle M A Fernando; Lora Boteva; David L Morris; Bi Zhou; Yee Ling Wu; Marja-Liisa Lokki; Chack Yung Yu; John D Rioux; Edward J Hollox; Timothy J Vyse
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

2.  Effects of C4 null alleles and homoduplications on quantitative expression of C4A and C4B.

Authors:  A Hammond; W Ollier; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

3.  Complement allotypes in familial and sporadic Alzheimer's disease.

Authors:  P K Panegyres; R L Dawkins
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

4.  The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.

Authors:  E R Holme; J Veitch; A Johnston; I C McKay; K Whaley
Journal:  Rheumatol Int       Date:  1992       Impact factor: 2.631

5.  Rearrangement of 21-hydroxylase genes in disease-associated MHC supratypes.

Authors:  M J Garlepp; A N Wilton; R L Dawkins; P C White
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

6.  Usefulness of densitometry in typing of human complement component C4.

Authors:  J Kramer; E Gyódi; G Füst
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

Review 7.  A review of major histocompatibility complex-disease associations in man and dog.

Authors:  M J Day; W J Penhale
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

8.  Quantitation of human C4A and C4B, in serum and plasma by enzyme-linked immunoadsorbent assay.

Authors:  E Holme; S J Cross; J Veitch; G J O'Neill; K Whaley
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  Ancestral haplotypes reveal the role of the central MHC in the immunogenetics of IDDM.

Authors:  M A Degli-Esposti; L J Abraham; V McCann; T Spies; F T Christiansen; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

10.  Serum C4 concentration in the monitoring of systemic lupus erythematosus: requirement for C4 allotyping.

Authors:  G Uko; F T Christiansen; R L Dawkins
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.